Researchers from the Rutgers Robert Wood Johnson Medical School and the Children's Hospital of Orange County discovered a ...

Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder characterized by a near-total absence of ...

A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...

Manufactured by Eli Lilly and Company, both Mounjaro and Zepbound contain the active ingredient tirzepatide. Tirzepatide is similar to semaglutide, which is used in medications like Ozempic, Rybelsus, ...

Love is in the air, and Hallmark will be one of the many networks focusing at least some of their programming around Valentine’s Day for the next month of the 2025 TV schedule. Fans of the ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as GLP-1 receptor agonists, including the popular name brands Ozempic, Wegovy, ...

Tirzepatide, the active ingredient in ... according to research published Jan. 29 in The New England Journal of Medicine. Congenital generalized lipodystrophy — a disorder that significantly ...

England boss Thomas Tuchel is reportedly open to calling up Championship players for international duty as he takes charge for the first time during their World Cup qualifying matches. England ...

Ophthalmic complications were observed in patients using semaglutide and tirzepatide, but a causal link was not established. The study included nine patients, with conditions like nonarteritic ...

according to a study in The New England Journal of Medicine. Congenital generalized lipodystrophy (CGL), which affects only a few thousand people worldwide, results in severe metabolic disease, ...